Human Vps13 proteins are associated with several diseases, including the neurodegenerative disorder Chorea-acanthocytosis (ChAc), yet the biology of these proteins is still poorly understood.
| INTRODUCTION
There is growing evidence that members of the human Vps13 protein family play a prominent role in health and disease. Defects in the expression and structure of all human VPS13 (hVPS13) genes are linked to multiple disorders, such as neurodegeneration and neurological diseases, cancers and diabetes. In particular, mutations in the hVPS13A gene lead to a complex and fatal disease known as Choreaacanthocytosis (ChAc). [1] [2] [3] Despite their relevance, the roles of Vps13 proteins in cell biology and in specific molecular processes are still unclear. In recent years, a number of studies have taken advantage of simple experimental models to investigate the function of Vps13 proteins more deeply. In this review, we summarize recent reports on the domain structure and functions of Vps13 proteins, and modeling of mutations found in ChAc disease. Particular attention will be given to studies focusing on the simple eukaryote Saccharomyces cerevisiae.
Other experimental models such as Tetrahymena thermophila, Dictyostelium discoideum and Drosophila melanogaster will also be discussed as they also contribute to understanding the complexity of Vps13 proteins. These studies have revealed the potential pathways affected in diseases associated with Vps13. These pathways are involved in: actin cytoskeleton organization; vesicle trafficking; regulation of membrane contact sites (MCSs) between organelles; mitochondrial function; phagocytosis and autophagy. Modeling of diseases in simple eukaryotes can shed light on the pathological mechanisms underlying the disease and may serve as experimental platforms for drug testing.
| HUMAN DISEASES ASSOCIATED WITH VPS13 GENES
In the human genome, there are 4 widely expressed genes encoding VPS13 proteins (here referred to as hVps13, for clarity): hVPS13A, hVPS13B, hVPS13C and hVPS13D. 4 Mutations or perturbations in the expression of these genes are associated with various human disorders (Table 1) . Mutations in hVPS13A lead to the rare hereditary disease -ChAc (OMIM 200150), [1] [2] [3] an autosomal recessive disorder characterized by adult-onset chorea, progressive neurodegeneration and abnormal erythrocyte morphology -acanthocytosis. 5 Mutations in hVPS13B cause Cohen syndrome (OMIM 216550), 6 a rare autosomal recessive disorder characterized by non-progressive psychomotor retardation, microcephaly, characteristic facial features, retinal dystrophy, and intermittent neutropenia in children, 7 but there are also reports of correlations with autism and other neurological disorders (Table 1) . The hVPS13C mutations are implicated in a distinct form of early-onset Parkinsonism (OMIM 616840) characterized by rapid and severe disease progression and early cognitive decline. 8 Genetic studies have also revealed that variants of hVPS13C are associated with an increased risk of diabetes. [9] [10] [11] [12] A genetic variation in the hVPS13D allele, which contributes to septic shock mortality, was also identified. 13 Furthermore, there are reports of putative associations of hVPS13A, hVPS13C and hVPD13D variations with schizophrenia. 14, 15 Finally, alterations in the expression level and/or mutations in all human VPS13 genes have been observed in specific cancers. d One of the mutation, that is M1I, is a missense mutation, but from the physiological point of view should be considered as a small deletion, since it causes start of translation from the second in-frame ATG codon resulting in 10-aa shortening of the protein at the N terminus.
phosphoinositides (PIPs). 30 The hVps13B protein is a peripheral membrane protein localized to the Golgi complex, is required for maintenance of the Golgi complex morphology 31 and is essential for the normal glycosylation of proteins. 32 The hVps13C protein is enriched in the outer membrane of mitochondria, 8 lipid droplets 33 and, based on cell fractionation studies, in early endosomes. 8 The hVps13C protein may also be involved in maintenance of mitochondrial morphology and vulnerability to stress. 8, 34 Furthermore, hVps13C participates in adipogenesis by binding galectin-12, a protein required for adipogenic signaling and adipocyte differentiation in vitro. 33 The hVps13D
protein regulates interleukin-6 (IL-6) production and/or transport, since silencing of the gene encoding hVps13D in HeLa cells significantly increased the IL-6 levels in the medium in both non-stimulated and stimulated conditions. 13 In summary, the hVps13 proteins are implicated in many key cellular processes and disrupting their functionality leads to severe disorders affecting a variety of tissues. , mouse 38 and others. 4 The high degree of conservation suggests that the functions of Vps13 family members have been preserved during evolution. Thus researchers use model organisms to study Vps13 proteins as well as the mechanisms of associated diseases.
In the amoeba D. discoideum, the absence of 1 of its 6 Vps13 homologues, called TipC (or DdVps13C), leads to an aberrant multicellular structure during development and to defective sporulation, phenotypes observed in many autophagy mutants. Autophagic flux was demonstrated to be impaired in the tipC mutant cells, which consistently accumulated ubiquitin positive structures, probably representing protein aggregates. 29 Similarly, it has been observed that the absence of a Vps13 homologue in D. melanogaster leads to the accumulation of ubiquitinated proteins and an increased α-synuclein-mediated neurodegeneration. 34, 39 However, whether these phenotypes in D. melanogaster are due to defective autophagy has not yet been investigated.
Phagocytosis is also altered in the tipC D. discoideum mutant, as a reduced rate of phagocytosis of fluorescent latex beads was observed. 29 Regarding this process, another 2 D. discoideum mutants, lacking different Vps13 homologues (DdVps13A and DdVps13F) have shown a specific defective phagocytosis of Micrococcus luteus and Klebsiella pneumoniae, respectively. 40 The specificity of the phagocytic defect with respect to different bacteria might suggest that distinct Vps13 proteins could have specialized functions within this process.
For instance, phagocytic internalization of fluorescent latex beads or heat-inactivated K. pneumoniae is not significantly altered in the Vps13F mutant. Instead, the phagocytic defect was attributed to an inefficient killing of internalized K. pneumoniae due to defective intracellular signaling. 40 Supporting a role for the Vps13 family in phagocytosis, 1 of 8 putative T. thermophila Vps13 homologues (TtVps13A) was identified as a component of phagosomes in a mass spectrometry analysis 41 and shown to localize at the membrane of phagosomes. 36 Furthermore, phagocytosis is reduced and phagocytic digestion is delayed in the absence of this T. thermophila Vps13 protein. 36 Endocytosis is another cellular process in which the Vps13 family has been shown to be involved. In particular, a D. melanogaster orthologue of human Vps13A co-fractionates with endosomal proteins and its absence results in reduced endocytosis rate. 39, 42 Taken together, these studies of the functions of Vps13 proteins in specific model organisms point to a role for Vps13 proteins in processes highly dependent upon membranes and vesicle trafficking and upon vacuolar/lysosomal degradation pathways. It is well known that a deficient degradative capacity of cells is involved in multiple human diseases, including the major neurodegenerative diseases, and thus these pathways should be considered as possible therapeutic targets for hVPS13-related diseases.
| YEAST AS A MODEL TO STUDY Vps13 PROTEINS
Due to the high evolutionary conservation of fundamental cellular processes within eukaryotes, the yeast S. cerevisiae has become a potent model organism to study the intricacies of human diseases, including neurodegenerative disorders. 43 57 Moreover, the APT1 domain between SHR-BD and ATG_C was identified in both human hVps13A and yeast Vps13
( Figure 1A) . 57 An independent HHsearch at the C-terminal region of
Vps13 revealed the presence of homology to the pleckstrin homology (PH) domains, which are typical docking sites for phosphatidylinositol lipids. 58 Homology to this domain was also found in hVps13A in our recent analysis using Phyre2 (Flis, unpublished result). Recently, using single-particle electron microscope analysis of negatively stained protein, an approximate 3D architecture of yeast Vps13 was determined 57, 61 and the amino acid transporter Can1. 57 Recent work suggests that Vps13 is required for normal sorting of Neo1 flippase on endosomes. 62 The observed defects in Golgi-to-vacuole transport and in endocytosis might occur as the result of misregulation of common components of both pathways or as a direct consequence of Vps13 deficiency, as it has been reported recently that Vps13 is directly required for Golgi-to-endosome transport and trans-Golgi homotypic fusion in vitro. 54 Similar to hVps13A, the Vps13 protein is involved in the regulation of the actin cytoskeleton network. Vps13 was found among proteins captured in an in vitro actin assembly assay using microbeads coated with nucleation promoting factor Las17 (yeast WASP) 63 and it binds to actin in immunoprecipitation assays. 57 Furthermore, the vps13Δ strain displays defects in actin cytoskeleton organization. 57 Additionally, it is worth mentioning that the internal diameter (6 nm) of the loop in the Vps13 structure is similar to the diameter of an F-actin filament, 54 further suggesting that Vps13 may directly interact and regulate the actin cytoskeleton network.
The actin cytoskeleton is important for many processes based on membrane dynamics, such as endocytosis, retrograde transport, 64, 65 and also for mitochondrial inheritance and integrity. 66, 67 Therefore, it was not surprising that, similarly to hVps13C, yeast Vps13 was found to be involved in mitochondrial homeostasis. The vps13Δ cells show increased rate of nuclear transfer of mitochondrial DNA (mtDNA)
indicating defects in mtDNA stability and mitochondrial integrity. 68 This could also be the reason for the increased rate of mitophagy observed in the vps13Δ strain.
68
Vps13 is also involved in sporulation, which is the yeast equivalent of gametogenesis. 69 During this process, 4 haploid nuclei are produced by meiosis and enveloped within a novel intracellular membrane called the prospore membrane. Sporulation efficiency is reduced~2500-fold in vps13Δ, 35 as a result of defects in the formation of prospore membranes, which are smaller and only about a quarter of them capture nuclei. 70 Upon sporulation, Vps13 translocates to the prospore membrane where it promotes expansion of the membrane and regulates its bending, and is also required for cytokinesis. 71 The observed defects in vps13Δ during sporulation are probably associated with the reduced levels of PI(4,5)P 2 and its precursor, PI4P, in the prospore membrane. 71 Initially, it was claimed that Vps13 localized to the cytoplasm and endosomes 72 and later to the prospore membrane. 71 Recently, it was demonstrated that Vps13 is also localized to the MCSs, where it may regulate their formation or function (Figure 2 ).
68,73
The MCSs are structures where two membranes are tethered in close proximity, but do not fuse. These junctions allow the exchange of ions, metabolites and lipids between membranes and organelles. 74 Depending on the carbon source, Vps13 was found in contact between mitochondria and vacuoles (called vacuole and mitochondria patches; vCLAMPs), between vacuole and the endoplasmic reticulum (ER)-derived nuclear envelope (known as the nuclearvacuolar junction; NVJ), and at the endosome-mitochondria junctions (EMJs). 68, 73 Deletion of VPS13 is synthetically lethal in combination with mutations of MMM1, encoding an integral ER membrane protein that is a subunit of the ER mitochondria encounter structure (ERMES) complex, tethering the ER and mitochondria. 68, 73 Also, dominant mutations in VPS13 suppress known ERMES complex-deficient phenotypes, probably by increasing the formation or function of vCLAMPs. 73, 75 This role in MCS is in agreement with the current reports that purified Vps13 exhibits ATP-stimulated binding to yeast membranes 54 and I2749R (see Table 2 for a list of human missense mutations investigated in yeast). Intriguingly, the effect of each of those mutations on Vps13 functioning in yeast cells was different, suggesting that a universal mechanism leading to ChAc disease may not exist.
No phenotypes were observed for the vps13-Y2702C variant, indicating that this mutation does not alter the function of the yeast protein in the processes tested. 68 In contrast, the vps13-L1107P mutant strain shows a defect in CPY sorting and lethality when also carrying mmm1Δ. Moreover, vps13-L66P and vps13-C89K were also synthetically lethal with mmm1Δ, but do not affect CPY sorting. Synthetic lethality with mmm1Δ demonstrates the inability of these vps13 variants to compensate for the loss of ERMES. 68 Finally, the vps13-I2749R yeast variant was inactive in all processes tested, suggesting a loss of function 57 (see Table 2 for a description of the associated phenotypes for these mutations). Importantly, the I2749R substitution, which is located in the APT1 domain, diminished binding of Vps13 to PI3P, suggesting that this binding is essential to all Vps13 functions. 57 Based on the homology of Vps13 to hVps13A and these recent findings, a model suggesting a possible mechanism of ChAc pathogenesis was proposed where I2771R substitution may reduce the binding of the APT1 domain of hVps13A to PI3P enriched membranes affecting hVps13A localization and/or function. 57 
| CONCLUSIONS AND FUTURE PERSPECTIVES
Yeast has greatly contributed to the study of a number of human disorders; however, its exploitation for the study of rare genetic diseases is still limited. The studies summarized in this review are a testimony to the potential of yeast models for unveiling the intricacies of human Vps13-related diseases, particularly ChAc. Addressing the lack of effective drugs is an important step in ChAc research.
ChAc molecular targets suitable for therapeutic intervention could be identified using yeast as a powerful tool for high-throughput genetic screening. In addition, high-throughput assay formats could also be explored as primary drug-screening platforms to filter for natural and synthetic small molecules with cytoprotective action towards ChAc pathological processes.
Other models, such as the social amoeba D. discoideum can complement the studies performed in yeast. In several aspects, this organism is more similar to animal cells than to fungi for processes such as phagocytosis, cell motility, development and the lysosomal and autophagic pathways. 
